Effect of Tailored vs Standard use of the Combined Oral Contraceptive on Continuation Rates at one year.

Trial Profile

Effect of Tailored vs Standard use of the Combined Oral Contraceptive on Continuation Rates at one year.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Apr 2013

At a glance

  • Drugs Ethinylestradiol/levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Oct 2012 Investigational drug identified as Ethinylestradiol/levonorgestrel as reported by European Clinical Trials Database.
    • 31 May 2012 Additional location (Scotland) added as reported by United Kingdom Clinical Research Network record.
    • 19 Nov 2010 United Kingdom Clinical Research Network reports accrual to date changed from 73% to 85%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top